"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 14 | 26 | 40 |
| 1996 | 15 | 19 | 34 |
| 1997 | 17 | 37 | 54 |
| 1998 | 23 | 26 | 49 |
| 1999 | 21 | 54 | 75 |
| 2000 | 19 | 55 | 74 |
| 2001 | 18 | 49 | 67 |
| 2002 | 23 | 68 | 91 |
| 2003 | 32 | 74 | 106 |
| 2004 | 32 | 69 | 101 |
| 2005 | 33 | 86 | 119 |
| 2006 | 26 | 80 | 106 |
| 2007 | 40 | 84 | 124 |
| 2008 | 38 | 68 | 106 |
| 2009 | 39 | 73 | 112 |
| 2010 | 30 | 75 | 105 |
| 2011 | 41 | 100 | 141 |
| 2012 | 39 | 83 | 122 |
| 2013 | 35 | 101 | 136 |
| 2014 | 69 | 99 | 168 |
| 2015 | 69 | 113 | 182 |
| 2016 | 76 | 93 | 169 |
| 2017 | 66 | 122 | 188 |
| 2018 | 70 | 125 | 195 |
| 2019 | 55 | 127 | 182 |
| 2020 | 38 | 151 | 189 |
| 2021 | 38 | 121 | 159 |
| 2022 | 1 | 120 | 121 |
| 2023 | 2 | 97 | 99 |
| 2024 | 28 | 71 | 99 |
| 2025 | 3 | 10 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells. Mol Cancer Res. 2025 Feb 06; 23(2):128-142.
-
Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variants. Brain. 2025 Feb 03; 148(2):564-579.
-
The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clin Cancer Res. 2025 Feb 03; 31(3):551-560.
-
The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):356-363.
-
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist. 2025 Jan 17; 30(1).
-
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):387-402.
-
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 Jan 16; 13(1):9.
-
Bi-allelic KICS2 mutations impair KICSTOR complex-mediated mTORC1 regulation, causing intellectual disability and epilepsy. Am J Hum Genet. 2025 Feb 06; 112(2):374-393.
-
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers. Cancer Discov. 2025 Jan 13; 15(1):119-138.
-
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12; 27(1):89-105.